These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38606953)

  • 21. Haemophilia gene therapy: From trailblazer to gamechanger.
    Evens H; Chuah MK; VandenDriessche T
    Haemophilia; 2018 May; 24 Suppl 6():50-59. PubMed ID: 29878653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WFH State-of-the-art paper 2020: In vivo lentiviral vector gene therapy for haemophilia.
    Cantore A; Naldini L
    Haemophilia; 2021 Feb; 27 Suppl 3(Suppl 3):122-125. PubMed ID: 32537776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice.
    Düchs MJ; Kratzer RF; Vieyra-Garcia P; Strobel B; Schönberger T; Groß P; Aljayyoussi G; Gupta A; Lang I; Klein H; Morilla SM; Hopf S; Park J; Kreuz S; Klugmann M; Igney FH
    Front Immunol; 2024; 15():1360063. PubMed ID: 38558809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease.
    Li Y; Miller CA; Shea LK; Jiang X; Guzman MA; Chandler RJ; Ramakrishnan SM; Smith SN; Venditti CP; Vogler CA; Ory DS; Ley TJ; Sands MS
    Mol Ther; 2021 Feb; 29(2):691-701. PubMed ID: 33388420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adeno-associated virus finds its disease.
    Russell DW; Grompe M
    Nat Genet; 2015 Oct; 47(10):1104-5. PubMed ID: 26417859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver directed adeno-associated viral vectors to treat metabolic disease.
    Chuecos MA; Lagor WR
    J Inherit Metab Dis; 2024 Jan; 47(1):22-40. PubMed ID: 37254440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AAV serotype 8-mediated liver specific GNMT expression delays progression of hepatocellular carcinoma and prevents carbon tetrachloride-induced liver damage.
    Fang CC; Wu CF; Liao YJ; Huang SF; Chen M; Chen YA
    Sci Rep; 2018 Sep; 8(1):13802. PubMed ID: 30217986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver gene therapy with intein-mediated F8 trans-splicing corrects mouse haemophilia A.
    Esposito F; Lyubenova H; Tornabene P; Auricchio S; Iuliano A; Nusco E; Merlin S; Olgasi C; Manni G; Gargaro M; Fallarino F; Follenzi A; Auricchio A
    EMBO Mol Med; 2022 Jun; 14(6):e15199. PubMed ID: 35491676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors.
    Meumann N; Schmithals C; Elenschneider L; Hansen T; Balakrishnan A; Hu Q; Hook S; Schmitz J; Bräsen JH; Franke AC; Olarewaju O; Brandenberger C; Talbot SR; Fangmann J; Hacker UT; Odenthal M; Ott M; Piiper A; Büning H
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpes simplex virus thymidine kinase-mediated suicide gene therapy for hepatocellular carcinoma using HIV-1-derived lentiviral vectors.
    Gerolami R; Uch R; Faivre J; Garcia S; Hardwigsen J; Cardoso J; Mathieu S; Bagnis C; Brechot C; Mannoni P
    J Hepatol; 2004 Feb; 40(2):291-7. PubMed ID: 14739101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy.
    Grimm D; Zhou S; Nakai H; Thomas CE; Storm TA; Fuess S; Matsushita T; Allen J; Surosky R; Lochrie M; Meuse L; McClelland A; Colosi P; Kay MA
    Blood; 2003 Oct; 102(7):2412-9. PubMed ID: 12791653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status of gene therapy for hepatocellular carcinoma, with a focus on gene delivery approaches.
    Wang X; Tai Z; Zhang W; Gao S
    Curr Gene Ther; 2015; 15(2):120-41. PubMed ID: 25537775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low incidence of hepatocellular carcinoma in mice and cats treated with systemic adeno-associated viral vectors.
    Ferla R; Alliegro M; Dell'Anno M; Nusco E; Cullen JM; Smith SN; Wolfsberg TG; O'Donnell P; Wang P; Nguyen AD; Chandler RJ; Chen Z; Burgess SM; Vite CH; Haskins ME; Venditti CP; Auricchio A
    Mol Ther Methods Clin Dev; 2021 Mar; 20():247-257. PubMed ID: 33473358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
    Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
    Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The complex, confusing and poorly understood immune responses to AAV-mediated gene transfer in haemophilia-Is more or less immunosuppression required?
    Tuddenham EGD; Foster GR
    J Viral Hepat; 2024 Apr; 31 Suppl 1():21-25. PubMed ID: 38606938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preferential targeting of disseminated liver tumors using a recombinant adeno-associated viral vector.
    Della Peruta M; Badar A; Rosales C; Chokshi S; Kia A; Nathwani D; Galante E; Yan R; Arstad E; Davidoff AM; Williams R; Lythgoe MF; Nathwani AC
    Hum Gene Ther; 2015 Feb; 26(2):94-103. PubMed ID: 25569358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HCV-related liver cancer in people with haemophilia.
    Meijer K; Haagsma EB
    Haemophilia; 2012 Jan; 18(1):17-24. PubMed ID: 21651676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
    Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.